Copper transport drug restores memory and clears toxic Alzheimer's proteins
Summary
A drug that modulates copper transport shows promise in restoring memory and clearing toxic Alzheimer's-associated proteins in preclinical models.
Similar Articles
Creatine raise brain energy levels and slow Alzheimer's cognitive decline by 30%
A 2025 review and pilot trial show that creatine supplementation raises brain energy levels and slows cognitive decline in early Alzheimer's patients by 30%, highlighting the supplement's overlooked neurological benefits.
Successful Psilocybin Treatment of Alzheimer
This case report documents transient multidomain functional improvements in an advanced Alzheimer's patient following high-dose psilocybin administration, with recovery of speech, continence, and social interaction over days to weeks.
UCLA discovers first stroke rehabilitation drug to repair brain damage (2025)
UCLA researchers developed DDL-920, a drug mimicking stroke rehabilitation effects in mice, published in Nature Communications. This breakthrough targets parvalbumin neurons to restore gamma oscillations and improve movement control.
@arcinstitute: The brain works hard to clear waste, and impairments are central to neurodegeneration. In @CellCellPress, Innovation In…
A new study in Cell maps how the brain clears waste, with implications for understanding neurodegeneration. Researchers tracked endogenous proteins to visualize waste removal pathways.
Medication-Aware Financial Exploitation Detection for Alzheimer's Patients Using Edge-Aware Interaction Risk Modeling
This paper proposes a medication-aware framework that integrates medication adherence data with transaction monitoring to detect cognitively risky financial events for Alzheimer's patients, showing improved recall during medication-induced vulnerability windows.